SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

  1. Iakounine, Alexandre

    Unigolyn: Academaidd